Tonix Pharmaceuticals Holding Corp (TNXP) Down 1.96% in Premarket Trading

Wednesday, August 31, 2022 09:01 AM | InvestorsObserver Analysts

Mentioned in this article

Tonix Pharmaceuticals Holding Corp (TNXP) is down Wednesday morning, with the stock losing -1.96% in pre-market trading to 1. TNXP's short-term technical score of 11 indicates that the stock has traded less bullishly over the last month than 89% of stocks on the market. In the Biotechnology industry, which ranks 126 out of 146 industries, Tonix Pharmaceuticals Holding Corp ranks higher than 21% of stocks. Tonix Pharmaceuticals Holding Corp has fallen 39.29% over the past month, closing at $1.77 on August 3. During this period of time, the stock fell as low as $1.02 and as high as $1.94. TNXP has an average analyst recommendation of Strong Buy. The company has an average price target of $13.00.

TNXP has an Overall Score of 47. Find out what this means to you and get the rest of the rankings on TNXP!
Tonix Pharmaceuticals Holding Corp has a Long-Term Technical rank of 58. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 42% of the market scoring higher. In the Biotechnology industry which is number 78 by this metric, TNXP ranks better than 78% of stocks.

Important Dates for Investors in TNXP:

-Tonix Pharmaceuticals Holding Corp is set to release earnings on 11/6/2022. Over the last 12 months, the company has reported EPS of $-6.66. -We do not have a set dividend date for Tonix Pharmaceuticals Holding Corp at this time. Click Here To Get The Full Report on Tonix Pharmaceuticals Holding Corp (TNXP)

Share this article: